MDT - Medtronic FY 2024 Q3 results bode well for future
2024-02-20 11:15:11 ET
More on Medtronic
- Medtronic Is A Healthy Portfolio Boost
- Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
- Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative
- Medtronic beats top-line and bottom-line estimates; raises FY24 outlook
- Medtronic Q3 in focus amid MedTech’s post-COVID gains